APA

Liu P., Cao W., Ma B., Li M., Chen K., Sideras K., Duitman J., Sprengers D., Khe Tran T. C., Ijzermans J. N. M., Biermann K., Verheij J., Spek C. A., Kwekkeboom J., Pan Q. & Peppelenbosch M. P. (20191107). Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma. : Carcinogenesis.

Chicago

Liu Pengyu, Cao Wanlu, Ma Buyun, Li Meng, Chen Kan, Sideras Kostandinos, Duitman Jan-Willem, Sprengers Dave, Khe Tran T C, Ijzermans Jan N M, Biermann Katharina, Verheij Joanne, Spek C Arnold, Kwekkeboom Jaap, Pan Qiuwei and Peppelenbosch Maikel P. 20191107. Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma. : Carcinogenesis.

Harvard

Liu P., Cao W., Ma B., Li M., Chen K., Sideras K., Duitman J., Sprengers D., Khe Tran T. C., Ijzermans J. N. M., Biermann K., Verheij J., Spek C. A., Kwekkeboom J., Pan Q. and Peppelenbosch M. P. (20191107). Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma. : Carcinogenesis.

MLA

Liu Pengyu, Cao Wanlu, Ma Buyun, Li Meng, Chen Kan, Sideras Kostandinos, Duitman Jan-Willem, Sprengers Dave, Khe Tran T C, Ijzermans Jan N M, Biermann Katharina, Verheij Joanne, Spek C Arnold, Kwekkeboom Jaap, Pan Qiuwei and Peppelenbosch Maikel P. Action and clinical significance of CCAAT/enhancer-binding protein delta in hepatocellular carcinoma. : Carcinogenesis. 20191107.